Loading clinical trials...
Loading clinical trials...
Phase II Randomized Trial of Mugard Compared With Best Supportive Care for Prevention and Treatment of Stomatitis in Women With Hormone Receptor Positive Breast Cancer Initiating Treatment With Everolimus-based Endocrine Therapy.
Conditions
Interventions
mucoadhesive oral wound rinse
laboratory biomarker analysis
Locations
1
United States
Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
Start Date
October 8, 2014
Primary Completion Date
November 30, 2018
Completion Date
November 30, 2018
Last Updated
September 21, 2020
NCT05467891
NCT05660083
NCT07483307
NCT06649331
NCT07379918
NCT04585750
Lead Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions